KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Capital BDC (CCAP) Liabilities and Shareholders Equity (2021 - 2025)

Crescent Capital BDC's Liabilities and Shareholders Equity history spans 5 years, with the latest figure at $1.6 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 2.06% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $6.6 billion, changed 0.36%, while the annual FY2025 figure was $1.6 billion, 2.06% down from the prior year.
  • Liabilities and Shareholders Equity reached $1.6 billion in Q4 2025 per CCAP's latest filing, roughly flat from $1.6 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.7 billion in Q2 2024 to a low of $1.3 billion in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: increased 24.91% in 2023, then fell 2.06% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.3 billion in 2021, then dropped by 1.13% to $1.3 billion in 2022, then rose by 24.91% to $1.6 billion in 2023, then grew by 1.78% to $1.7 billion in 2024, then fell by 2.06% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for CCAP's Liabilities and Shareholders Equity are $1.6 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.7 billion (Q2 2025).